pixantrone has been researched along with panobinostat in 1 studies
Studies (pixantrone) | Trials (pixantrone) | Recent Studies (post-2010) (pixantrone) | Studies (panobinostat) | Trials (panobinostat) | Recent Studies (post-2010) (panobinostat) |
---|---|---|---|---|---|
92 | 16 | 59 | 678 | 95 | 593 |
Protein | Taxonomy | pixantrone (IC50) | panobinostat (IC50) |
---|---|---|---|
Histone deacetylase 8 | Schistosoma mansoni | 0.45 | |
Histone deacetylase 3 | Homo sapiens (human) | 0.2031 | |
Bromodomain-containing protein 4 | Homo sapiens (human) | 0.005 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 0.0033 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.3792 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.181 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.9434 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.2527 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.007 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.8396 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.46 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.2307 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.5825 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.3424 | |
Histone deacetylase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0025 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flögel, B; Greil, R; Jöhrer, K; Kircher, B; Willenbacher, E; Willenbacher, W | 1 |
1 review(s) available for pixantrone and panobinostat
Article | Year |
---|---|
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Topics: Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Female; Humans; Isoquinolines; Leukemia, Plasma Cell; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Multiple Myeloma; Panobinostat; Retrospective Studies | 2019 |